September 2023 BCOP Test - Ampullary Adenocarcinoma: Overview of Subtypes and Treatments
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
December 2023 BCOP Test - Advances in Targeted Therapy for Biliary Tract Cancers
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
December 2023 BCOP Test - Updates in the Treatment of Adult Acute Lymphoblastic Leukemia
The test is available for an additional fee of $50. Each activity is this series is worth 1 hour of BCOP credit. Save $10 per test by purchasing the 6-test bundle!
Category
Format
Credits
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™
This program features updates to the NCCN Guidelines; new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies, including acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia/small lymph
Category
Format
Credits
Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia
Learn about the recent advances as well as the challenges involved in the diagnosis and management of classical hairy cell leukemia (HCL) and HCL-variant.
Category
- Non-Hodgkin's Lymphoma
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Recorded Presentation from the NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New Therapeutic Target
The flurry of changes to the PARPi indications can cause considerable confusion in clinical practice. It may be difficult for health care professionals to keep track of the emerging data and understand how to apply it to patient care. It is important that health care professionals, including pharmacists, are able to educate their patients on the risks vs. benefits of these agents to help empower them to make informed decisions regarding their treatment.
Category
- Ovarian Cancer
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas
Learn about the challenges associated with the management of transformed indolent lymphomas and the recent advances in management to help you to incorporate novel therapies into routine clinical practice in the appropriate patient population to improve clinical outcomes.
Category
- Non-Hodgkin's Lymphoma
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
A Model for Responding to Chemotherapy Infusion Hypersensitivity Reactions
Hypersensitivity treatment algorithms and standing orders provide the nurse with the opportunity to feel confident in their ability to manage hypersensitivity and enable them to intervene earlier. Early intervention may lead to better outcomes for the patient and the potential for completion of treatments versus changes to the treatment plan.
Category
- Supportive Care Topics
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Management of Colorectal Cancer
Continued education on the advancements of colorectal cancer will help bridge knowledge gaps and improve the quality of care offered to patients.
Category
- Colorectal Cancer
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation
Bispecific Antibodies: A New Frontier in Immunotherapy
The advances in immunotherapy in cancer care are ever-changing and complex. It is integral for nurses to have current knowledge of bispecific antibody therapies in hematologic malignancies and to understand their mechanisms of action and side effect profiles to support optimal patient outcomes.
Category
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
Format
- Recorded Webcast
Credits
- 0.75 ANCC contact hours
- 0.75 Participation